TACR1 and familial primary hypomagnesemia: Accordingly, blocking NK1R using aprepitant improves cardiac functions in erlotinib-treated rats by reducing erlotinib-induced hypomagnesemia and subsequent SP elevation, thereby, inhibiting SP-induced oxidative/inflammation stress [48].